Volition is developing simple, easy to use blood-based Nu.Q™ immunoassay tests to accurately diagnose a range of cancers. Our first test, the Nu.Q™ colorectal cancer screening triage test, is designed to identify patients who have received a false positive result on their FIT test and ensures that fewer patients are referred for unnecessary colonoscopies. Diagnostic tests for people with symptoms for colorectal cancer as well as a screening test for average risk populations are in development.